TABLE 2.
Estimated cumulative 5-year cost per patient of melanoma-related treatment
WLE only | WLE + SLNB | |
---|---|---|
Baseline model (no systemic therapy) | $2480 | $10,220 |
PD-1 antibody* for SLN+ patients | $2480 | $25,300 |
PD-1 antibody* for node basin recurrence | $12,210 | $11,280 |
PD-1 antibody* for SLN+ or for node basin recurrence | $12,210 | $26,360 |
Cost of PD-1 antibody based on pembrolizumab dosed Q3 weeks for 1 year